Scientific Program

  • Thursday, March 14
  • Friday, March 15
  • Saturday, March 16

Thursday, March 14

[JS01] KAI-KSH Joint Symposium: Immunotherapeutics in Blood Disease

Date & Time March 14 (Thursday) 09:00-10:30 Room Vista I

Immune checkpoint inhibitor in cancer

Seung-Woo Lee (POSTEC, Korea)

Towards next-generation CAR-T cell therapy for cancer

Chan Hyuk Kim (KAIST, Korea)

Cytotoxic T lymphocyte therapy

Hyewon Lee (National Cancer Center, Korea)

Immune checkpoint inhibitor in lymphoma

Yoon Seok Choi (Chungnam National University College of Medicine, Korea)

[SS01] Scientific Session 1: Bone Marrow Failure

Date & Time March 14 (Thursday) 09:00-10:30 Room Vista II

Paroxysmal nocturnal hemoglobinuria in bone marrow failure

Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)

Germline mutations in inherited BM failure

Jean Soulier (University Paris Diderot, France)

Telomere length and somatic mutations in aplastic anaemia

Dong Soon Lee (Seoul National University School of Medicine, Korea)

[PL01] Plenary Lecture I: Gene Therapy in Hematology

Date & Time March 14 (Thursday) 10:45-11:45 Room Vista I+II+III

Application of CRISPR/Cas-9 in blood disease

Matthew H. Porteus (Stanford Medical School, Stanford University, USA)

Gene therapy for hemophilia

Katherine Ann High (Spark Therapeutics Inc., USA)

[PS] Presidential Symposium

Date & Time March 14 (Thursday) 11:45-12:45 Room Vista I+II+III

Stem cells in human AML

Ravindra Majeti (Stanford University, USA)

Precision medicine in pediatric acute lymphoblastic leukemia

Ching-Hon Pui (St. Jude Children's Research Hospital, USA)

[LS01] Novatis

Date & Time March 14 (Thursday) 12:45-13:35 Room Vista I

Treatment Free Remission in CML: Promise and challenges

Adam Mead (University of Oxford, UK)

[LS02] Amgen

Date & Time March 14 (Thursday) 12:45-13:35 Room Vista II+III

Optimal treatment sequencing for patients with relapsed/refractory multiple myeloma

Ajai Chari (Mount Sinai Hospital, USA)

[LS03] Roche

Date & Time March 14 (Thursday) 12:45-13:35 Room Grand Hall

Current issues in the treatment of B-cell lymphoma

Seok Jin Kim (Sungkyunkwan University school of Medicine, Korea)

[AS01] Asian Hematology Symposium I: Lymphoid

Date & Time March 14 (Thursday) 13:40-14:40 Room Vista I

NHL in India

T. Raja (Apollo Hospital, India)

Hematopoietic stem cell transplantation for adult acute lymphoblastic Leukemia in Taiwan – On Behalf of TSBMT

Tran-Der Tan (Koo Foundation Sun Yat-Sen Cancer Center, Taiwan)

ALL in Malaysia

Sen Mui Tan (Hospital Ampang, Malaysia)

[AS02] Asian Hematology Symposium II: Myeloid

Date & Time March 14 (Thursday) 13:40-14:40 Room Vista II

CML in Phillippines

Priscilla Caguioa (University of Santo Tomas Hospital, St. Luke’s Medical Center, Philippines)

Outcome of allogeneic hematopoietic stem cell transplantation for SAA and PNH at Vietnam national institute of haematology and blood transfusion

Vo Thi Thanh Binh (National Institute of Hematology and Blood Transfusion, Vietnam)

Hemoglobinopathy in Thailand

Suradej Hongeng (Ramathibodi Hospital, Mahidol University, Thailand)

[JS02] KOGO-KSH Joint Symposium: Genomics for Precision Hematology

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista I

Understanding angioimmunoblastic T-cell lymphoma: From genomics to animal pathology

Jaesang Kim (Ewha Womans University College of Natural Science, Korea)

Genomic pathogenesis of Epstein–Barr Virus (EBV)-induced diffuse large B cell lymphoma

Sung-Yup Cho (Seoul National University College of Medicine, Korea)

Current status of precision hematology

Young-Uk Cho (University of Ulsan College of Medicine, Korea)

Clinical application of precision hematology

Joon-Ho Moon (Kyungpook National University Hospital, Korea)

[SS02] Scientific Session 2: Multiple Myeloma-How is Multiple Myeloma Developed and Progressed? From 3 Different Viewpoint

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista II

Strategy to overcome treatment resistance in high risk multiple myeloma

Lugui Qiu (Chinese Academy of Medical Sciences and Peking Union Medical College, China)

Roles of bone marrow microenvironment in clonal evolution and drug resistance of multiple myeloma

Yusuke Furukawa (Jichi Medical University, Japan)

Antigen-mediated regulation in MM

Madhav Dhodapkar (Winship Cancer Institute of Emory University, USA)

[SS03] Scientific Session 3: Transplantation/Cell Therapy

Date & Time March 14 (Thursday) 14:55-16:25 Room Vista III

TK cell therapy

Maria Chiara Bonini (Università Vita-Salute San Raffaele, School of Medicine, Italy)

Updates on CAR T cell therapy for multiple myeloma

Jesús G. Berdeja (Sarah Cannon Research Institute, USA)

Accelerating personalization of immune therapies for blood cancers

Larry W. Kwak (City of Hope Comprehensive Cancer Center, USA)

[ES01] Educational Session 1: Iron Metabolism

Date & Time March 14 (Thursday) 14:55-16:25 Room Grand Hall

Iron metabolism in hemoglobinopathies

Vip Viprakasit (Medicine Siriraj Hospital, Mahidol University, Thailand)

Deferasirox for iron overload patients: preserving organ functions

Norbert Gattermann (Heinrich Heine University, Düsseldorf, Germany)

Management of iron overload in MDS

Heather Alice Leitch (University of British Columbia, Canada)

[SS04] Scientific Session 4: Myeloproliferative Neoplasm

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista I

Clinical significance of genetic stratification of MPN patients

Robert Kralovics (CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Austria)

Molecular mechanism of MPN development by mutant calreticulin

Norio Komatsu (Juntendo University School of Medicine, Japan)

Interferon treatment for MPN

Jean-Jacques Kiladjian (Paris 7 University , France)

[SS05] Scientific Session 5: Bleeding Disorder/Thrombosis

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista II

Progress in gene therapy for hemophilia A and B

Glenn F. Pierce (World Federation of Hemophilia, USA)

Individualized treatment for hemophilia : population pharmacokinetics approach

Cindy Yeung (McMaster University, Canada)

Mechanisms of cancer-associated thrombosis

Nigel Mackman (University of North Carolina, USA)

[SS06] Scientific Session 6: Pediatric Disease: Inherited hematologic malignancies

Date & Time March 14 (Thursday) 16:40-18:10 Room Vista III

Inherited hematologic malignancies

Lucy Ann Godley (The University of Chicago, USA)

GATA2 leukemogenesis

Jean Donadieu (APHP Trousseau, France)

Roles of Monosomy 7 and SAMD9/SAMD9L mutations in myeloid leukemogenesis

Hirotaka Matsui (Kumamoto University, Japan)

[ES02] Educational Session 2: Indolent Lymphoma: From Genetics to the Clinic

Date & Time March 14 (Thursday) 16:40-18:10 Room Grand Hall

Mantle cell lymphoma -from the clinic to genetics

Mats Jerkeman (Lund University, Sweden)

From genetics to the clinic: Follicular lymphoma

Gilles Salles (Université Claude Bernard Lyon—1 (UCBL), France)

From genetics to the clinic of chronic lymphocytic leukemia

Wei Xu (First Affiliated Hospital of Nanjing Medical University, China)